Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients-Reference-Cited by-同舟云学术

Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipients

Published:2021-03-19 Issue:10 Volume:87 Page:3901-3909
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit Jnl Clinical Pharma

Author:

Sallustio Benedetta C.¹²^ORCID,Noll Benjamin D.³,Hu Rong⁴,Barratt Daniel T.²,Tuke Jonathan⁵⁶,Coller Janet K.²^ORCID,Russ Graeme R.⁷,Somogyi Andrew A.²^ORCID

Affiliation:

1. Department of Clinical Pharmacology Basil Hetzel Institute, The Queen Elizabeth Hospital Woodville South SA 5011 Australia

2. Discipline of Pharmacology, Adelaide Medical School University of Adelaide Adelaide SA 5000 Australia

3. School of Pharmacy and Medical Sciences University of South Australia Australia Adelaide SA 5000 Australia

4. Department of Pharmacy, Guangzhou Women's and Children's Medical Centre Guangzhou Medical University Guangzhou China

5. ARC Centre for Excellence for Mathematical and Statistical Frontiers School of Mathematical Sciences Adelaide SA 5000 Australia

6. School of Mathematical Sciences Adelaide SA 5000 Australia

7. Central Northern Adelaide Renal and Transplantation Services, Royal Adelaide Hospital Adelaide SA 5000 Australia

Funder

Australian Research Council

National Health and Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14806

Reference48 articles.

1. Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation

2. Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

3. RELATIONSHIP OF FK506 WHOLE BLOOD CONCENTRATIONS AND EFFICACY AND TOXICITY AFTER LIVER AND KIDNEY TRANSPLANTATION

4. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report

5. Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determining the Main Infection Courts in Sweet Cherry Trees of the Canker Pathogens Calosphaeria pulchella, Cytospora sorbicola, and Eutypa lata;Plant Disease;2024-06-01

2. Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions;Expert Review of Clinical Pharmacology;2024-05-16

3. Genotype‐Guided Model for Prediction of Tacrolimus Initial Dosing After Lung Transplantation;The Journal of Clinical Pharmacology;2024-02-08

4. Drug–drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different CYP3A5 genotypes;Therapeutic Advances in Drug Safety;2024-01

5. Tacrolimus—why pharmacokinetics matter in the clinic;Frontiers in Transplantation;2023-08-21